Supernus Pharmaceuticals | SUPN - 营业利润

金融业

USD 28.89

USD 1.4B

现金及等价物

USD 175.88M

USD 59M

USD 711.22M

USD 285.4M

USD 40.17M

USD -21.04M

USD 55.6M

674

EPS每股收益

USD 0.35

股本和储备

USD 1.06B

USD 176.53M

债务利息支出

USD 718K

USD 2.63M

USD 400.38M

USD 1.6B

USD -58.37M

USD 1.06B

USD -21.04M

普通股股本

USD 58.16M

72.26

USD 22.71M

USD 226.8M

销售和管理费用

USD 133.64M

USD 113.24M

贸易债权人

USD 8.52M

应收帐款人

USD 211.66M

	营业利润	更改		日
Abbott	USD 1.36B		775M	2026-09
ANI Pharmaceuticals	USD 51.84M		12M	2026-09
Aurora Cannabis	CAD -8.73M		1.3M	2026-06
Bristol-Myers Squibb	USD 255M		44M	2026-09
Canopy Growth	CAD -17.58M		9.9M	2026-06
Cara Therapeutics	USD -7.05M		1.11M	2026-03
Corcept Therapeutics	USD 114.72M		73.42M	2026-09
Eisai	JPY 16.7B		8.03B	2026-09
Eli Lilly	USD 12.46B		2.68B	2026-06
Novo Nordisk	DKK 33.76B		25.86B	2026-06
Pacira	USD 2.57B		2.56B	2026-09
Perrigo	USD 27.2M		3.7M	2026-09
Pfizer	USD 662M		5M	2026-09
Supernus Pharmaceuticals	USD -21.04M		14.21M	2026-06
United Therapeutics	USD 241.3M		89.5M	2026-09
Xeris Pharmaceuticals	USD 5.17M		2.74M	2026-06